Industry News
-
Verve is latest gene editing company to suffer setback, as Vertex walks away from pact
Feb 27 2025 -
FDA Accepts for Review Precigen RRP Gene Therapy Candidate
Feb 26 2025 -
FDA removes clinical hold on Entrada’s Duchenne therapy
Feb 25 2025 -
Pfizer ends rollout of Beqvez, putting another dent in hemophilia gene therapy field
Feb 21 2025 -
MeiraGTx gene therapy allows 11 blind children to see as biotech eyes accelerated approval
Feb 21 2025 -
Scientists develop largest ever biological AI model that ‘thinks in nucleotides’
Feb 19 2025 -
Exclusive: CRISPR delivery startup, based on UC Berkeley and UCSF science, shuts down
Feb 19 2025 -
Ultragenyx Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for UX111, an AAV Gene Therapy for Sanfilippo Syndrome Type A (MPS IIIA)
Feb 19 2025 -
Solid Biosciences Announces Positive Initial Data from Phase 1/2 INSPIRE DUCHENNE Trial for SGT-003, a Next-Generation Gene Therapy for Duchenne Muscular Dystrophy
Feb 19 2025